CNS-话题@MedSci

#CNS#

70篇内容 | 2642人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1914267, encodeId=a506191426eac, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=盘点：用时最短！中国学者突破100篇CNS生命科学领域成果；高福/饶子和/秦川都大于4篇；上海科技大学及山东农业大学表现出色, objectType=article, longId=198223, objectId=f15019822356, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f15019822356, replyNumber=0, likeNumber=102, createdTime=2020-11-11, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f15019822356, moduleTitle=盘点：用时最短！中国学者突破100篇CNS生命科学领域成果；高福/饶子和/秦川都大于4篇；上海科技大学及山东农业大学表现出色, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f15019822356)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914262, encodeId=fcbb191426261, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=2019 WCLC ∣奥希替尼160mg为EGFR T790M突变阳性伴CNS转移NSCLC患者带来显著获益, objectType=article, longId=179499, objectId=164d1e9499e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=164d1e9499e1, replyNumber=0, likeNumber=72, createdTime=2020-02-01, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=164d1e9499e1, moduleTitle=2019 WCLC ∣奥希替尼160mg为EGFR T790M突变阳性伴CNS转移NSCLC患者带来显著获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=164d1e9499e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914261, encodeId=6fa219142610c, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=【CNS学院·大咖说】刘安文教授： EGFR突变阳性晚期NSCLC脑转移防治策略, objectType=article, longId=178512, objectId=7fb11e8512e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fb11e8512e3, replyNumber=0, likeNumber=92, createdTime=2020-02-22, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fb11e8512e3, moduleTitle=【CNS学院·大咖说】刘安文教授： EGFR突变阳性晚期NSCLC脑转移防治策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fb11e8512e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914257, encodeId=c577191425e48, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNS Drugs：SSRIs在改善脑卒中后功能结局上有何作用？, objectType=article, longId=152035, objectId=fa181520355c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa181520355c, replyNumber=0, likeNumber=72, createdTime=2019-09-01, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa181520355c, moduleTitle=CNS Drugs：SSRIs在改善脑卒中后功能结局上有何作用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa181520355c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914260, encodeId=35b21914260d2, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=BLOOD：基于伊布替尼的联合方案治疗复发/难治CNS淋巴瘤效果显著, objectType=article, longId=166158, objectId=fd4816615892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd4816615892, replyNumber=0, likeNumber=59, createdTime=2019-05-19, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd4816615892, moduleTitle=BLOOD：基于伊布替尼的联合方案治疗复发/难治CNS淋巴瘤效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd4816615892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914253, encodeId=d1a71914253aa, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Blood：泊马度胺联合地塞米松可有效治疗难治性/复发性原发性CNS或玻璃体视网膜淋巴瘤, objectType=article, longId=149948, objectId=038214994893, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=038214994893, replyNumber=0, likeNumber=74, createdTime=2019-07-02, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=038214994893, moduleTitle=Blood：泊马度胺联合地塞米松可有效治疗难治性/复发性原发性CNS或玻璃体视网膜淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=038214994893)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914255, encodeId=3e861914255ac, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNS Drugs：抗精神病药增加儿童和青少年体重 “神药”二甲双胍能减重吗？, objectType=article, longId=151723, objectId=8431151e234f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8431151e234f, replyNumber=0, likeNumber=105, createdTime=2019-10-06, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8431151e234f, moduleTitle=CNS Drugs：抗精神病药增加儿童和青少年体重 “神药”二甲双胍能减重吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8431151e234f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914249, encodeId=52c219142491c, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNS Drugs：安眠药唑吡坦：增加驾驶风险？, objectType=article, longId=144209, objectId=00a11442093d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00a11442093d, replyNumber=0, likeNumber=63, createdTime=2019-01-10, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00a11442093d, moduleTitle=CNS Drugs：安眠药唑吡坦：增加驾驶风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00a11442093d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914259, encodeId=5e3a191425974, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Neurology：TSPO PET 有助于诊断 CNS 血管炎, objectType=article, longId=156349, objectId=538215634929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=538215634929, replyNumber=0, likeNumber=70, createdTime=2019-10-17, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=538215634929, moduleTitle=Neurology：TSPO PET 有助于诊断 CNS 血管炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=538215634929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914256, encodeId=1c8e191425604, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNS Drugs：精神分裂症患者的社会心理功能，氯氮平PK其他抗精神病药物, objectType=article, longId=151724, objectId=c889151e24f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c889151e24f0, replyNumber=0, likeNumber=94, createdTime=2019-08-11, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c889151e24f0, moduleTitle=CNS Drugs：精神分裂症患者的社会心理功能，氯氮平PK其他抗精神病药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c889151e24f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914254, encodeId=4ae519142548c, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Qual Life Res：儿科CNS肿瘤和其他癌症生存者听力损失和生活质量研究, objectType=article, longId=151456, objectId=f7a215145688, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7a215145688, replyNumber=0, likeNumber=77, createdTime=2018-11-28, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7a215145688, moduleTitle=Qual Life Res：儿科CNS肿瘤和其他癌症生存者听力损失和生活质量研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7a215145688)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914245, encodeId=7db919142458d, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNStroke2018丨中国心源性卒中的现状与发展——房颤与卒中的新进展, objectType=article, longId=137611, objectId=1e8013e611d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e8013e611d5, replyNumber=0, likeNumber=79, createdTime=2019-02-19, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e8013e611d5, moduleTitle=CNStroke2018丨中国心源性卒中的现状与发展——房颤与卒中的新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e8013e611d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914258, encodeId=318b1914258f1, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Neurology：鉴别 RCVS 和 PACNS 的大型研究, objectType=article, longId=154122, objectId=c96215412202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c96215412202, replyNumber=0, likeNumber=98, createdTime=2019-02-18, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c96215412202, moduleTitle=Neurology：鉴别 RCVS 和 PACNS 的大型研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c96215412202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914243, encodeId=0925191424393, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNS Drugs：降低缺血性卒中后癫痫风险就靠这种神药, objectType=article, longId=137212, objectId=a80613e21287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a80613e21287, replyNumber=0, likeNumber=0, createdTime=2018-12-06, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a80613e21287, moduleTitle=CNS Drugs：降低缺血性卒中后癫痫风险就靠这种神药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a80613e21287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914252, encodeId=30671914252e7, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Blood：超糖基化SAMD14和神经蛋白-I是原发性中枢神经系统淋巴瘤的CNS自身抗原, objectType=article, longId=149618, objectId=13c11496183b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c11496183b, replyNumber=0, likeNumber=110, createdTime=2019-06-21, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c11496183b, moduleTitle=Blood：超糖基化SAMD14和神经蛋白-I是原发性中枢神经系统淋巴瘤的CNS自身抗原, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13c11496183b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914238, encodeId=0cdf19142386c, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNS Drugs：丙戊酸治疗2年后还有必要进行年度实验室随访吗？, objectType=article, longId=125575, objectId=84211255e562, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84211255e562, replyNumber=0, likeNumber=66, createdTime=2018-04-24, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84211255e562, moduleTitle=CNS Drugs：丙戊酸治疗2年后还有必要进行年度实验室随访吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84211255e562)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914246, encodeId=0691191424605, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNStroke2018丨陈可冀教授：中国中西医结合回顾与展望, objectType=article, longId=137612, objectId=9aaa13e61257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9aaa13e61257, replyNumber=0, likeNumber=0, createdTime=2018-05-31, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9aaa13e61257, moduleTitle=CNStroke2018丨陈可冀教授：中国中西医结合回顾与展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9aaa13e61257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914247, encodeId=658c191424eb9, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=CNS Drugs：缓解MS患者视网膜轴索变性不妨试试这个药, objectType=article, longId=142550, objectId=cc031425500b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc031425500b, replyNumber=0, likeNumber=64, createdTime=2019-04-23, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc031425500b, moduleTitle=CNS Drugs：缓解MS患者视网膜轴索变性不妨试试这个药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc031425500b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914251, encodeId=b3eb1914251d1, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=2018 CNS/AANS循证指南：胸腰段脊柱损伤患者的评估和治疗, objectType=article, longId=148997, objectId=4f2a14899ea6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f2a14899ea6, replyNumber=0, likeNumber=76, createdTime=2019-04-29, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f2a14899ea6, moduleTitle=2018 CNS/AANS循证指南：胸腰段脊柱损伤患者的评估和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f2a14899ea6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1914236, encodeId=cded19142365a, content=<a href='/topic/show?id=4b8349356f' target=_blank style='color:#2F92EE;'>#CNS#</a>, objectTitle=Am J Hematol：EPOCH联合利妥昔单抗治疗的淋巴瘤患者CNS复发率如何？, objectType=article, longId=119137, objectId=94bf11913e4a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94bf11913e4a, replyNumber=0, likeNumber=114, createdTime=2018-05-19, rootId=0, userName=lg.zhao, userId=c737344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94bf11913e4a, moduleTitle=Am J Hematol：EPOCH联合利妥昔单抗治疗的淋巴瘤患者CNS复发率如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94bf11913e4a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CNS

2020-05-29

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

盘点：用时最短！中国学者突破100篇CNS生命科学领域成果；高福/饶子和/秦川都大于4篇；上海科技大学及山东农业大学表现出色

2020-11-11

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

2019 WCLC ∣奥希替尼160mg为EGFR T790M突变阳性伴CNS转移NSCLC患者带来显著获益

2020-02-01

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

【CNS学院·大咖说】刘安文教授： EGFR突变阳性晚期NSCLC脑转移防治策略

2020-02-22

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNS Drugs：SSRIs在改善脑卒中后功能结局上有何作用？

2019-09-01

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

BLOOD：基于伊布替尼的联合方案治疗复发/难治CNS淋巴瘤效果显著

2019-05-19

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Blood：泊马度胺联合地塞米松可有效治疗难治性/复发性原发性CNS或玻璃体视网膜淋巴瘤

2019-07-02

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNS Drugs：抗精神病药增加儿童和青少年体重 “神药”二甲双胍能减重吗？

2019-10-06

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNS Drugs：安眠药唑吡坦：增加驾驶风险？

2019-01-10

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Neurology：TSPO PET 有助于诊断 CNS 血管炎

2019-10-17

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNS Drugs：精神分裂症患者的社会心理功能，氯氮平PK其他抗精神病药物

2019-08-11

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Qual Life Res：儿科CNS肿瘤和其他癌症生存者听力损失和生活质量研究

2018-11-28

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNStroke2018丨中国心源性卒中的现状与发展——房颤与卒中的新进展

2019-02-19

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Neurology：鉴别 RCVS 和 PACNS 的大型研究

2019-02-18

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNS Drugs：降低缺血性卒中后癫痫风险就靠这种神药

2018-12-06

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Blood：超糖基化SAMD14和神经蛋白-I是原发性中枢神经系统淋巴瘤的CNS自身抗原

2019-06-21

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNS Drugs：丙戊酸治疗2年后还有必要进行年度实验室随访吗？

2018-04-24

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNStroke2018丨陈可冀教授：中国中西医结合回顾与展望

2018-05-31

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

CNS Drugs：缓解MS患者视网膜轴索变性不妨试试这个药

2019-04-23

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

2018 CNS/AANS循证指南：胸腰段脊柱损伤患者的评估和治疗

2019-04-29

lg.zhao (审核中...)

前往app查看评论内容

#CNS#

Am J Hematol：EPOCH联合利妥昔单抗治疗的淋巴瘤患者CNS复发率如何？

2018-05-19

科室
- - 订阅+
  - 更多科室
工具
服务